HP12 DPS DIN 01975927
Health Canada record
| Active ingredient(s) | TIN 12 X; SPONGIA TOSTA 12 X; ANTIMONY POTASSIUM TARTRATE 12 X; SENEGA 3 X; PHOSPHORUS 6 X; LYCOPODIUM 6 X |
|---|---|
| Dosage form | Drops |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 04-Oct-1996 |
| Current status date | 29-Aug-2006 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00677795 | STANNUM MET GOUTTE 4-30CH | BOIRON LABORATOIRES | Drops | TIN 4 CH | Cancelled Post Market |
| 00855243 | STANNUM MET GRANULES 4CH | HOMEOCAN INC. | Tablet | TIN 4 CH | Cancelled Post Market |
| 02234138 | STANNUM METALLICUM | HOMEOCAN INC. | Globules; Drops; Granules | TIN 3 X | Cancelled Post Market |
| 02234766 | STANNUM METALLICUM | DOLISOS CANADA INC. | Granules; Liquid; Globules | TIN 3 X | Cancelled Post Market |
| 02233810 | STANNUM METALLICUM | SEROYAL INTERNATIONAL INC. | Tablet; Granules; Globules; Liquid; Drops; Pellet | TIN 3 X | Cancelled Post Market |
| 00670618 | STANNUM METALLICUM GLOBULE 4CH - 30CH | BOIRON LABORATOIRES | Tablet | TIN 4 CH | Cancelled Post Market |
| 00668141 | STANNUM METALLICUM GOUTTE 4CH-30CH | DOLISOS LABORATOIRES S.A. | Drops | TIN 3 CH | Cancelled Post Market |
| 00699608 | STANNUM METALLICUM GRANULE 4CH - 30CH | DOLISOS LABORATOIRES S.A. | Tablet | TIN 4 CH | Cancelled Post Market |
| 02232631 | STANNUM METALLICUM PRAEPARATUM | WELEDA AG HEILMITTELBETRIEBE | Liquid; Powder | TIN 3 D | Cancelled Post Market |
| 02232630 | STANNUM METALLICUM PRAEPARATUM OINTMENT | WELEDA AG HEILMITTELBETRIEBE | Ointment | TIN 3 D | Cancelled Post Market |
| 00858676 | STANNUM PWR 6X | KOEGLER LABORATORIES INC. | Powder | TIN 6 X | Cancelled Post Market |
| 02070189 | STANNUM-INJEEL LIQ (12D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | TIN 12 D | Cancelled Post Market |
International API supply for TIN
1549 active FDA Drug Master Files.
Special Access Programme
This molecule appears on Health Canada's list of drugs most often requested through the Special Access Programme.
Request a quote for HP12 DPS